| Literature DB >> 27801482 |
Evelyze Pinheiro Dos Reis1, Débora Martins Paixão1, Otávio José Bernardes Brustolini2, Fabyano Fonseca E Silva1, Walmir Silva1, Flávio Marcos Gomes de Araújo3, Anna Christina de Matos Salim3, Guilherme Oliveira4, Simone Eliza Facioni Guimarães1.
Abstract
This study used qRT-PCR to examine variation in the expression of 13 myogenes during muscle development in four prenatal periods (21, 40, 70 and 90 days post-insemination) in commercial (the three-way Duroc, Landrace and Large-White cross) and local Piau pig breeds that differ in muscle mass. There was no variation in the expression of the CHD8, EID2B, HIF1AN, IKBKB, RSPO3, SOX7 and SUFU genes at the various prenatal ages or between breeds. The MAP2K1 and RBM24 genes showed similar expression between commercial and Piau pigs but greater expression (p < 0.05) in at least one prenatal period. Pair-wise comparisons of prenatal periods in each breed showed that only the CSRP3, LEF1, MRAS and MYOG genes had higher expression (p < 0.05) in at least one prenatal period in commercial and Piau pigs. Overall, these results identified the LEF1 gene as a primary candidate to account for differences in muscle mass between the pig breeds since activation of this gene may lead to greater myoblast fusion in the commercial breed compared to Piau pigs. Such fusion could explain the different muscularity between breeds in the postnatal periods.Entities:
Year: 2016 PMID: 27801482 PMCID: PMC5127148 DOI: 10.1590/1678-4685-GMB-2015-0295
Source DB: PubMed Journal: Genet Mol Biol ISSN: 1415-4757 Impact factor: 1.771
GenBank accession numbers, primer sequences and amplicon sizes of the genes analyzed in this study.
| Gene | Accession number | Primer sequences (5’ → 3’) | Amplicon size |
|---|---|---|---|
| CHD8 | XM_003482263.1 | F: AGTGAGGACGAGAAGGAAGA | 104 |
| R: GGGAATCCATCTTGGGACATAG | |||
| CSRP3 | NM_001172368.1 | F: CAGCAACCCTTCCAAGTTCA | 91 |
| R: CATCACCTTCTCAGCAGCATAG | |||
| EID2B | XM_003127131.1 | F: CGCCACTATCTGGAACACTAC | 122 |
| R: CGCTGATATTCGGCATCAAAC | |||
| HIF1AN | XM_003359328.1 | F: GTACTGGTGGCATCACATAGAG | 118 |
| R: CTGATGGGCTTTGAGAGGATATT | |||
| IKBKB | NM_001099935.1 | F: GATGGCGACAGTCAGGAAAT | 107 |
| R: TTGCAAACCACCGTCTTACT | |||
| LEF1 | NM_001129967.1 | F: CTATTGTAACGCCTCAGGTCAA | 99 |
| R: TTGGCTCTTGCTCCTTTCTC | |||
| MAP2K1 | NM_001143716.1 | F: GGAGCTGGAGCTGATGTTT | 110 |
| R: GTCGGCTGTCCATTCCATAA | |||
| MRAS | XM_003358570.2 | F: GGTCGATTTGATGCATTTGAGG | 96 |
| R: TCCTTGGCACTGGTTTCTATG | |||
| MYOG | NM_001012406.1 | F: CAGGCTCAAGAAGGTGAATGA | 118 |
| R: GCACTCGATGTACTGGATGG | |||
| RBM24 | XM_001925447.3 | F: TACCTGCCCACTATGTCTATCC | 118 |
| R: GCAGCTCCCGTGTAATCAAT | |||
| RSPO3 | NM_032784.4 | F: GAAACACGGGTCCGAGAAATA | 110 |
| R: CCCTTCTGACACTTCTTCCTTT | |||
| SOX7 | XM_003359052.1 | F: TCTCCACTCCAACCTCCA | 120 |
| R: TCATTGCGATCCATGTCCTC | |||
| SUFU | XM_001928912.4 | F: GGAGCCCTCATTCCTCTTTG | 83 |
| R: GCCATGTCACCTGTGATACTT | |||
| ACTB | XM_003124280.3 | F: AAGATCAAGATCATCGCGCCTCCA | 108 |
| R: ACTCCTGCTTGCTGATCCACATCT | |||
| GAPDH | NM_001206359.1 | F: ACAGTCTTCTGGGTGGCAGTGAT | 176 |
| R: CATGTTTGTGATGGGCGTGAACAA | |||
| HPRT1 | NM_001032376.2 | F: GCTGACCTGCTGGATTACAT | 101 |
| R: CTGGTCATTACAGTAGCTCTTCAG |
Amplicon size in nucleotide number,
Reference gene. CHD8 – chromodomain helicase DNA binding protein 8, CSRP3 – cysteine and glycine-rich protein 3, EID2B – EP300 interacting inhibitor of differentiation 2B, HIF1AN – hypoxia inducible factor 1, α subunit inhibitor, IKBKB - inhibitor of κ light polypeptide gene enhancer in B-cells, kinase β, LEF1 – lymphoid enhancer-binding factor 1, MAP2K1 – mitogen-activated protein kinase kinase 1, MRAS – muscle RAS oncogene homolog, MYOG – myogenin (myogenic factor 4), RBM24 – RNA binding motif protein 24, RSPO3 – R-spondin 3, SOX7 – SRY (sex determining region Y)-box 7, SUFU – suppressor of fused homolog, ACTB – β-actin, GAPDH – glyceraldehyde-3-phosphate dehydrogenase, HPRT1 – hypoxanthine phosphoribosyltransferase 1.
Figure 1Functional gene networks and their interactions, showing the relationship between 13 genes (green). Twelve important subnets related to muscle development were included in biological process (pink), molecular function (violet) and metabolic pathway (yellow).
Metabolic pathways and gene ontologies for genes represented in the gene network.
| Gene ontologies | ||||
|---|---|---|---|---|
| Gene | Metabolic pathway | Cellular component | Molecular function | Biological process |
| CHD8 | WNT signaling pathway | Nuclear lumen | Histone and DNA binding | Embryo development |
| CSRP3 | – | Cytoskeleton | Contractile fiber | Muscle organ development/Muscle structure development/Muscle system process |
| EID2B | – | Nucleus | Muscle differentiation | Muscle organ development |
| HIF1AN | – | Nucleus/cytosol | Protein binding | Muscle organ development/Muscle structure development |
| IKBKB | MAPK signaling pathway | Nucleus/cytosol | Protein binding | Muscle system process/Musculoskeletal movement/Skeletal muscle contraction |
| LEF1 | WNT signaling pathway | Nucleus | Chromatin and DNA binding | Embryo development |
| MAP2K1 | MAPK signaling pathway | Cytoskeleton/cytosol/nucleus | Protein kinase activity | Muscle system process |
| MRAS | MAPK signaling pathway | Intracellular | GTPase activity/nucleotide binding | Muscle organ development/Organ development |
| MYOG | – | Nucleus | Chromatin and DNA binding | Muscle organ development/Muscle structure development |
| RBM24 | – | Nucleus/cytoplasm | Nucleotide binding | Muscle organ development/Organ development |
| RSPO3 | – | Extracellular region | Receptor binding | Embryo development |
| SOX7 | – | Nucleus/cytoplasm | Nucleic acid binding | Embryo development |
| SUFU | Hedgehog signaling pathway | Nucleus/cytoplasm | Transcription corepressor activity | Embryo development/Organ development |
P-values for ANOVA in relation to Breed, Period and interaction Breed x Period for the genes studied.
| Genes | Factors | ||
|---|---|---|---|
| Breed | Period | Breed x Period | |
| CHD8 | 0.9764 | 0.3615 | 0.6094 |
| CSRP3 | 0.8615 |
|
|
| EID2B | 0.9072 | 0.1615 | 0.4284 |
| HIF1AN | 0.5757 | 0.2535 | 0.5533 |
| IKBKB | 0.7473 | 0.6656 | 0.6948 |
| LEF1 | 0.9772 |
|
|
| MAP2K1 | 0.4445 |
| 0.0712 |
| MRAS | 0.6557 |
|
|
| MYOG | 0.7314 |
|
|
| RBM24 | 0.9866 |
| 0.1756 |
| RSPO3 | 0.7198 | 0.0885 | 0.2230 |
| SOX7 | 0.3451 | 0.4870 | 0.6915 |
| SUFU | 0.6504 | 0.2974 | 0.4175 |
Values in bold were statistically significant (p < 0.05) by F-Test;
P-values for two-period comparisons for the genes MAP2K1 and RBM24. The ANOVA results (F-test) for these genes were significant for the factor Period.
| Genes | Comparisons | |||||
|---|---|---|---|---|---|---|
| 21d x 40d | 21d x 70d | 21d x 90d | 40d x 70d | 40d x 90d | 70d x 90d | |
| MAP2K1 |
| 0.0772 | 0.1882 | 0.1177 |
| 0.6143 |
| RBM24 |
|
|
| 0.9412 | 0.9917 | 0.9495 |
21d, 40d, 70d and 90d indicate the prenatal ages. Values in bold were statistically significant (p < 0.05).
Figure 2Relative expression levels for two genes (MAP2K1 and RMB24) in pair-wise comparisons of prenatal ages (21, 40, 70 and 90 days post-insemination). These genes differed significantly in relation to the factor ‘Period’ (p < 0.05, F-test in ANOVA), but showed no significant difference for the interaction ‘Breed x Period’. *p < 0.05 and **p < 0.01 indicates significant pair-wise comparisons by Student's t-test. A positive fold-change means that the first period in the comparison shows greater expression than the second period. Negative fold-change means that the second period in comparison presents greater expression than the first period.
P-values for two-period comparisons in commercial and Piau pigs. The ANOVA results (F-test) for these genes showed a significant Breed x Period interaction.
| Genes | Breed | Comparisons | |||||
|---|---|---|---|---|---|---|---|
| 21d x 40d | 21d x 70d | 21d x 90d | 40d x 70d | 40d x 90d | 70d x 90d | ||
| CSRP3 | Commercial |
|
|
| 0.2524 | 0.3070 | 0.8964 |
| Piau |
|
|
| 0.2719 | 0.3062 | 0.9365 | |
| LEF1 | Commercial | 0.5880 |
|
|
|
| 0.9356 |
| Piau |
|
|
| 0.4091 | 0.1052 | 0.3973 | |
| MRAS | Commercial | 0.0575 | 0.8639 | 0.3663 |
|
| 0.4609 |
| Piau | 0.1992 | 0.3261 | 0.1414 |
|
| 0.6007 | |
| MYOG | Commercial |
|
|
| 0.2565 | 0.7099 | 0.4366 |
| Piau |
|
|
| 0.4341 | 0.5396 | 0.8629 | |
21d, 40d, 70d and 90d indicate the prenatal ages. Values in bold were statistically significant (p < 0.05) by Student's t-test.
Figure 3Relative expression for four genes (CSRP3, LEF1, MRAS and MYOG) in pair-wise comparisons of prenatal ages (21, 40, 70 and 90 days post-insemination) in commercial and Piau pigs. These genes showed a significant interaction for Breed x Period (p < 0.05, F-test in ANOVA). *p < 0.05 and **p < 0.01 indicates significant pair-wise comparisons by Student's t-test. A positive fold-change means that the first period in the comparison shows greater expression than the second period. Negative fold-change means that the second period in the comparison presents greater expression than the first period.